Graham Capital Management, L.P. Ngm Biopharmaceuticals Inc Transaction History

Graham Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.72 - $5.4 $298,098 - $432,723	-80,134 Reduced 71.06%	32,643 $133,000
Q4 2022 Feb 14, 2023	BUY	$3.41 - $12.93 $384,569 - $1.46 Million	112,777 New	112,777 $566,000
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $132,165 - $218,610	12,492 New	12,492 $160,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.